Literature DB >> 4810289

A system for the clinical staging of lung cancer.

C F Mountain, D T Carr, W A Anderson.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4810289     DOI： 10.2214/ajr.120.1.130

Source DB:  PubMed          Journal:  Am J Roentgenol Radium Ther Nucl Med        ISSN： 0002-9580


× No keyword cloud information.
  44 in total

1.  Interpretation of graphic data by patients in a general medicine clinic.

Authors:  D J Mazur; D H Hickam
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Survival in lung cancer.

Authors:  R D Reynolds; B R Greenberg; R Hill; R N Lucas; J H Shirley
Journal:  West J Med       Date:  1977-09

3.  Chest diseases-epitomes of progress: the staging of lung cancer: clinical benefits.

Authors:  F N Firestone
Journal:  West J Med       Date:  1977-10

4.  Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival.

Authors:  F A Greco; R L Richardson; S F Schulman; S Stroup; R K Oldham
Journal:  Br Med J       Date:  1978-07-01

Review 5.  Oncology imaging: nodal spread-intrathoracic nodes.

Authors:  J A Verschakelen; P de Leyn; J Bogaert; A L Baert
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

6.  Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.

Authors:  T A Zikos; A D Donnenberg; R J Landreneau; J D Luketich; V S Donnenberg
Journal:  Cancer Immunol Immunother       Date:  2011-03-05       Impact factor: 6.968

7.  Management of lung cancer.

Authors:  S G Spiro
Journal:  BMJ       Date:  1990-12-08

Review 8.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

9.  How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party.

Authors:  J S Thomas; D Lamb; T Ashcroft; B Corrin; C W Edwards; A R Gibbs; W E Kenyon; R J Stephens; W F Whimster
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

10.  [New TNM classification of malignant lung tumors 2009 from a pathology perspective].

Authors:  A Fisseler-Eckhoff
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.